AWS for Industries

Nima Alidoust

Author: Nima Alidoust

Nima Alidoust, Ph.D. is the co-founder and CEO of Vevo Therapeutics. Over the last decade, Nima has been leading engineering, scientific and business teams at the intersection of computational chemistry, advanced compute, and AI. Prior to founding Vevo, Nima was the CEO of the Computational Chemistry Division at 1QBit (now spun out as Good Chemistry Company) and VP of Product and Strategy at Rigetti Computing ($RGTI). He also spent 2 years at McKinsey & Co, where he primarily served clients on strategy, corporate finance, and innovation topics. Nima received his PhD from Princeton University, focusing on computational and quantum chemistry. He received his BA from Middlebury College in Physics and Classics.

Executive Conversations with Nosis Bio and Vevo: Using Generative AI on AWS to Shift the Pharmaceutical R&D Paradigm

Today, organizations are looking to harness the power of generative AI, including foundation models (FMs) and large language models (LLMs) to innovate faster to reinvent patient outcomes. While this has created a lot of hype, the adoption of these technologies in real-world drug development is still a challenge for most organizations. Amrita Sarkar, Principal Healthcare […]